Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-010623
Filing Date
2013-06-19
Accepted
2013-06-19 17:59:03
Documents
1
Period of Report
2013-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4957
  Complete submission text file 0001179110-13-010623.txt   6542
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HBM BIOVENTURES (CAYMAN) LTD. CENTENNIAL TOWERS,STE.305,2454 W.BAY RD. GRAND CAYMAN E9 E9
Business Address
Wicki Andreas (Reporting) CIK: 0001511472 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 13922911